Can I reliably measure my own sleep quality?

Partly. Standardized questionnaires like the PSQI capture subjective sleep experience over several weeks well and are suited for observing changes or preparing for a doctor's appointment. But they cannot measure actual sleep architecture – how much deep sleep or REM sleep you have; that is reliably achieved only through polysomnography in a sleep laboratory. Wearables estimate sleep stages only indirectly and can be off the mark.

Does DSIP really help with falling asleep?

That is not established. A few small, older human studies hinted at weak effects, but a 2006 review explicitly describes the connection between DSIP and sleep as an "unresolved riddle" and points out that even the basic biology is unclear. DSIP is not an approved sleep aid but a research substance. Efficacy claims should be understood as an unproven assertion.

What helps best with stress-related sleep problems?

For chronic, stress-related sleep disorders, the most robust evidence lies with cognitive behavioral therapy for insomnia (CBT-I), which guidelines regard as the first-line therapy – not with a substance or peptide. It targets sleep habits, rumination patterns, and persistent inner tension. For ongoing complaints, a medical or psychotherapeutic evaluation is advisable, also to rule out treatable physical causes.

Sleep7 min readLast reviewed: June 2026

Measuring Sleep and Understanding Sleep Disorders: Sleep Architecture, Self-Tests, and an Honest Look at Sleep Peptides

From the outside, sleep looks like a simple off-state, but it is a highly structured, active process that unfolds across the night in recurring cycles. Anyone who wants to understand sleep problems has to face two questions: how is healthy sleep actually built, and how can you sensibly assess your own sleep? This article explains sleep architecture in a beginner-friendly way, places well-known self-tests such as the Pittsburgh Sleep Quality Index (PSQI) into context as a concept, and shows how stress throws sleep off rhythm. At the end, we honestly assess what is behind "sleep peptides" such as the Delta sleep-inducing peptide (DSIP) – and why the evidence there is considerably weaker than the hype suggests. One thing up front: this text is no substitute for a medical evaluation; persistent sleep disorders belong in professional hands.

Machine-assisted translation. The German original is the authoritative version.

Key points

Sleep is highly structured: non-REM (N1–N3) and REM alternate in ~90–120-minute cycles; deep sleep serves recovery and immune function, REM serves emotional processing.
Self-tests like the PSQI capture subjective sleep experience over weeks well, but do not measure objective sleep architecture – that requires polysomnography.
Stress produces hyperarousal and can set off a vicious cycle of poor sleep and more tension; for chronic insomnia, cognitive behavioral therapy (CBT-I) is the best-documented treatment.
"Sleep peptides" like DSIP sound promising, but the evidence is thin: a 2006 review calls the DSIP-sleep connection an "unresolved riddle."
DSIP is not an approved sleep aid but a research substance – for persistent sleep problems, a medical evaluation is the right path, not self-medication.

Sleep Architecture: What Really Happens During a Night

Healthy sleep does not proceed uniformly; it is divided into stages that repeat across the night in cycles of roughly one and a half to two hours. Technically, experts distinguish non-REM sleep with stages N1, N2, and N3, as well as REM sleep (Rapid Eye Movement), in which most vivid dreams occur. N1 is the light transition from wakefulness to sleep, N2 makes up the largest share of the night, and N3 is deep sleep (also called slow-wave sleep), in which the brain shows the slowest, largest waves.

These stages have different jobs. Deep sleep is considered especially important for physical recovery and for memory and regeneration processes; a review article in Physiological Reviews also describes how closely deep sleep is intertwined with the function of the immune system, supporting, for example, the formation of immunological memory. REM sleep, in turn, plays a role in emotional processing and in learning. An important point for context: the proportions of the stages shift across the night – deep sleep tends to dominate in the first half of the night, while REM phases grow longer toward morning. For this reason alone, "sleeping through the night" is not a state of absolute unconsciousness, and brief moments of wakefulness between cycles are normal.

Non-REM sleep is divided into N1 (light), N2 (the main share), and N3 (deep/slow-wave sleep)
REM sleep: vivid dreams, emotional processing, learning
Deep sleep is closely linked to physical recovery and immune function
The stages alternate in cycles of ~90–120 minutes; their proportions shift across the night
Brief waking periods between cycles are normal, not a sign of a disorder

Assessing Your Own Sleep: Self-Tests as a Concept

To capture sleep quality, research uses standardized questionnaires. The best known is the Pittsburgh Sleep Quality Index (PSQI), introduced in 1989 by Buysse and colleagues. It asks about sleep behavior over the past four weeks and bundles it into seven components – including subjective sleep quality, sleep latency, sleep duration, sleep efficiency, nighttime disturbances, use of sleep medication, and daytime impairment. From these, an overall score is derived. In the original validation study, a threshold value separated "good" from "poor" sleepers with high sensitivity and specificity. Such screening values (mentioned here in the sense of a concept) are useful for getting a feel for your own sleep quality over the course of weeks.

What matters, however, is what a questionnaire can do – and what it cannot. Self-tests reflect subjective experience and are well suited for observing changes over time or preparing for a conversation with a doctor. But they do not measure actual sleep architecture: how much deep sleep or REM sleep someone really has can only be captured with instruments, with the gold standard being polysomnography in a sleep laboratory. Common wearables and apps, too, only estimate sleep stages indirectly (for instance via movement and heart rate) and can be off the mark. A questionnaire or tracker statistic can therefore raise a suspicion, but it does not replace a medical diagnosis – for example, when a sleep-related breathing disorder is suspected.

PSQI (Buysse et al., 1989): seven components on sleep quality over the past four weeks
Self-tests capture subjective experience and trends – not objective sleep architecture
The gold standard for sleep stages is polysomnography in a sleep laboratory
Wearables/apps estimate stages only indirectly and can be inaccurate
Striking scores are a reason to talk to a doctor, not a finished diagnosis

When Stress Throws Sleep Off Rhythm

One of the most common causes of disrupted sleep is stress. The connection is physiologically easy to follow: sustained tension keeps the body in a state of heightened alertness (often described as "hyperarousal"), in which falling asleep becomes difficult and sleep becomes shallower and more fragmented. Typical signs are prolonged sleep onset, nighttime rumination, and early waking. A vicious cycle often develops: poor sleep increases sensitivity to stress the next day, and worry about sleep itself becomes an additional stressor.

This vicious cycle is at the core of so-called chronic insomnia. Remarkably, the most effective and best-documented treatment here is not a substance but a structured method: cognitive behavioral therapy for insomnia (CBT-I), which guidelines regard as the first-line therapy. It targets sleep habits, thought patterns, and hyperarousal. This is an important point for anyone looking for a quick pharmacological solution: for stress-related sleep problems, the most robust evidence lies with behavioral and psychological approaches, not with substances. We describe this here only for context – concrete treatment decisions belong in professional care.

Stress produces "hyperarousal": harder sleep onset, shallower, fragmented sleep
Vicious cycle: poor sleep → more stress → even worse sleep
Chronic insomnia is a distinct, treatable disorder
Best evidence for chronic insomnia: cognitive behavioral therapy (CBT-I), not substances
Have persistent sleep problems evaluated medically/psychotherapeutically

Sleep Peptides Like DSIP: Big Name, Little Proof

In the peptide community, "sleep peptides" are promoted, foremost among them the Delta sleep-inducing peptide (DSIP). The name alone raises expectations – it suggests that the peptide specifically produces deep delta-wave sleep. Historically, DSIP was isolated in 1977 from the cerebral venous blood of rabbits and proposed as a possible sleep-promoting messenger. In the early 1980s, a few small human studies, such as one by Schneider-Helmert and Schoenenberger (1981), reported somewhat longer sleep duration and better sleep quality after intravenous administration in people with chronic insomnia.

But the evidence is considerably weaker than the name suggests. A widely cited review in the Journal of Neurochemistry (Kovalzon & Strekalova, 2006) bears the telling title "a still unresolved riddle." The authors note that the connection between DSIP and sleep was never really established, that the original DSIP showed no reliable sleep-promoting effect in animal experiments, and that even the associated gene, protein, and a possible receptor have not been clearly isolated. In other words: despite a suggestive name and decades of research, it remains unclear whether and how DSIP reliably works in humans. The available human data come from very small, older studies with mixed results – this is not a solid foundation but an open chapter of research. Claims that DSIP is a proven sleep aid should therefore be classified as an assertion, not as an established fact.

DSIP was isolated in 1977 and proposed as a possible sleep factor
Small, older human studies (e.g. 1981) reported mixed, weak effects
2006 review: connection to sleep an "unresolved riddle," gene/receptor not clearly isolated
In animal experiments, the original DSIP showed no reliable sleep-promoting effect
The suggestive name is no substitute for solid human evidence – efficacy claims remain unproven

Status, Risks, and an Honest Assessment

Anyone considering "sleep peptides" should know their regulatory status. DSIP is not an approved medication for sleep disorders; it is to be classified as a research or investigational substance for which no officially recognized sleep indication exists. Outside controlled studies, purity, quality, dose-response relationship, and long-term safety are unclear. This is precisely why this article deliberately names no amounts, usage schemes, or sources: such recommendations lack a scientific and legal basis, and decisions of that kind belong in medical hands.

The sober overall assessment is this: sleep can be understood, observed, and roughly assessed with standardized self-tests – but only the sleep laboratory measures objective architecture. For stress-related and chronic sleep problems, the best evidence lies with behavioral methods, not with substances. "Sleep peptides" like DSIP are an interesting but immature field of research whose promises far exceed the data. Anyone who consistently sleeps poorly is better served by a medical evaluation – including to rule out treatable causes such as breathing disorders, thyroid, or hormonal problems – than by a peptide from the internet.

DSIP is to be classified as a research/investigational substance, not an approved sleep aid
Outside studies: purity, quality, and long-term safety are unclear
Best evidence for chronic/stress-related sleep problems lies with behavioral methods
No self-medication with unregulated peptides – prefer a medical evaluation
If a hormonal/metabolic cause is suspected (e.g. thyroid), have it evaluated medically

Related substance profiles

DSIP

A neuropeptide with contradictory sleep evidence — not approved.

Frequently asked questions

Can I reliably measure my own sleep quality?: Partly. Standardized questionnaires like the PSQI capture subjective sleep experience over several weeks well and are suited for observing changes or preparing for a doctor's appointment. But they cannot measure actual sleep architecture – how much deep sleep or REM sleep you have; that is reliably achieved only through polysomnography in a sleep laboratory. Wearables estimate sleep stages only indirectly and can be off the mark.
Does DSIP really help with falling asleep?: That is not established. A few small, older human studies hinted at weak effects, but a 2006 review explicitly describes the connection between DSIP and sleep as an "unresolved riddle" and points out that even the basic biology is unclear. DSIP is not an approved sleep aid but a research substance. Efficacy claims should be understood as an unproven assertion.
What helps best with stress-related sleep problems?: For chronic, stress-related sleep disorders, the most robust evidence lies with cognitive behavioral therapy for insomnia (CBT-I), which guidelines regard as the first-line therapy – not with a substance or peptide. It targets sleep habits, rumination patterns, and persistent inner tension. For ongoing complaints, a medical or psychotherapeutic evaluation is advisable, also to rule out treatable physical causes.

Sources

This article is for information and education only. It does not replace medical advice and deliberately contains no dosing, usage or sourcing information.

← All guide articles